For example, while we concluded that Uretero1 TM met the criterion for substantial clinical improvement, we note that CMS agreed that the evidence demonstrated improved outcomes for the disposable device (singular), i.e., Uretero1 TM (87 FR 71932)
Expected 12-week outcome without AOD-9604: approximately 5-6 kg total weight loss, roughly 3.5-4 kg from fat, 1-2 kg from lean tissue and water
We will generally get back to all inquiries in 24 hours
If you have trouble with nutrient absorption due to the presence of intestinal inflammation, poor gut health, or a deficiency of those intrinsic factors we mentioned, then taking an oral supplement may not be that helpful
We note that we accept a variety of information as part of the New Technology APC application process
for the broader recovery peptide context, see Healing & Recovery Peptides Explained